← All trials
NCT04920838
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 12, 2021
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2021
- First posted
- Jun 10, 2021
- Last posted
- Jun 10, 2021
- Enrollment
- 600
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of FranceLead sponsor
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- University of BarcelonaCollaborator
- Centre MurazCollaborator
- University of BordeauxCollaborator
- Alliance for International Medical ActionCollaborator
- Programme PACCI AbidjanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.